TPCW
AVNS

TD Private Client Wealth’s Avanos Medical AVNS Stock Holding History

TD Private Client Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323 Hold
13
– – ﹤0.01% 1602
2026
Q1 		$182 Hold
13
– – ﹤0.01% 1582
2025
Q4 		$146 Buy
+13
New +$149 ﹤0.01% 1575

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

TD Private Client Wealth's AVNS Position: Q2 2026 in Review

TD Private Client Wealth held its Avanos Medical (AVNS) position steady in Q2 2026 at 13 shares worth $323. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

TD Private Client Wealth first reported a position in AVNS in Q4 2025 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • TD Private Client Wealth held 13 shares of Avanos Medical worth $323 as of Q2 2026.
  • TD Private Client Wealth left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1602 holding.
  • TD Private Client Wealth first reported a position in Avanos Medical in Q4 2025 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.